SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-18-049689
Filing Date
2018-09-17
Accepted
2018-09-17 17:00:38
Documents
1
Group Members
JACK C. BENDHEIM

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tv502662_sc13da.htm SC 13D/A 78874
  Complete submission text file 0001144204-18-049689.txt   80572
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Subject) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-88114 | Film No.: 181074013
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 FRANK W. BURR BLVD., STE 21 TEANECK NJ 07666
Business Address 300 FRANK W. BURR BLVD., STE 21 TEANECK NJ 07666 2013297300
BFI Co., LLC (Filed by) CIK: 0001601607 (see all company filings)

IRS No.: 262105186 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A